Overall and subgroup analysis If the OVERALL results show highly significant evidence of a worthwhile effect of treatment, but a few subgroups of the overview unexpectedly…

Sample Size 1 _ Lecture 15 Some Evidence that Sample Size is Not Considered Carefully: A Survey of 71 “Negative” Trials (Freiman et al., NEJM, 1978) Authors stated “no…

What is Risk Prediction? Andrew N. Freedman, PhD Clinical and Translational Epidemiology Branch National Cancer Institute EGRP, DCCPS, NCI June 11, 2014 “Prediction is…

Central Statistical Monitoring in Clinical Trials Central Statistical Monitoring in Clinical Trials Amy Kirkwood Statistician CR UK and UCL Cancer Trials Centre IMMPACT-XVIII…

Overdiagnosis in mammography screening for breast cancer in Sweden and Norway Senior Statistician Per-Henrik Zahl, MA MD PhD Norwegian Institute of Public Health Professor…

Slide 1 Multiple Imputation of missing data in longitudinal health records Irene Petersen and Cathy Welch Primary Care & Population Health Today Issues with missing data…

Bone Quality PART 1 Introduction Architecture Turnover A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with…

Stage-specific survival of screen-detected versus clinically diagnosed colorectal cancer - evidence from the FOBT screening trials- Iris Lansdorp-Vogelaar Janneke Wilschut…

HIV incidence among women is associated with their partners' circumcision status in the township of Orange Farm, South Africa (ANRS-12126) K. Jean, P. Lissouba, D. Taljaard,…

LECTURE 15 - 97 Inclusion and Exclusion Criteria (Defining the Study Population) General considerations Run-in periods (enrichment) Regression toward the mean Some Issues…